Company Filing History:
Years Active: 2009-2012
Title: Diana M Ahrens: Innovator in Antibody Research
Introduction
Diana M Ahrens is a prominent inventor based in Mahopac, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of high-affinity human antibodies. With a total of 4 patents to her name, Ahrens is recognized for her innovative approaches to treating diseases related to interleukin-4 activity.
Latest Patents
Ahrens' latest patents include groundbreaking work on high-affinity human antibodies to the human IL-4 receptor. One of her notable inventions is an isolated human antibody or antigen-binding fragment that binds to the human interleukin-4 receptor alpha (hIL-4Rα) with an affinity constant (K) of less than 200 pM, as measured by surface plasmon resonance. Additionally, she has developed methods for treating diseases or disorders that can be improved by reducing interleukin-4 (IL-4) activity. These methods involve administering an antibody or antigen-binding fragment that specifically binds to the human IL-4 receptor.
Career Highlights
Diana Ahrens is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to advance her research in antibody development. Her work has been instrumental in the ongoing efforts to create effective treatments for various medical conditions.
Collaborations
Some of her coworkers include Sean Stevens and Tammy T Huang, who collaborate with her on various projects within the company.
Conclusion
Diana M Ahrens is a distinguished inventor whose work in antibody research has the potential to transform therapeutic approaches for diseases influenced by interleukin-4. Her contributions to the field are invaluable, and her ongoing research promises to yield further advancements in biotechnology.